Farther Finance Advisors, LLC

Position in CLDX — Celldex Therapeutics, Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in CLDX

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$8,037

-$2,240 QoQ

Shares Held

216

-33.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#220

of 252 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $15,699,251 across 282 Biotechnology names. CLDX ranks #124 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,922	$2,444,905
2	MRNA	Moderna, Inc.	15,429	$1,080,492
3	ARWR	Arrowhead Pharmaceuticals, Inc.	12,088	$985,292
4	HALO	Halozyme Therapeutics, Inc.	11,241	$879,833
5	EXEL	Exelixis, Inc.	14,171	$771,044
6	REGN	Regeneron Pharmaceuticals, Inc.	1,075	$670,305
7	VKTX	Viking Therapeutics, Inc.	15,171	$591,820
8	BMRN	Biomarin Pharmaceutical Inc	7,871	$450,378

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,037	216	-33.3%	Shares	Sole	2026-07-17
2026-03-31	$10,277	324	+69.6%	Shares	Sole	2026-04-07
2025-12-31	$5,187	191	0.0%	Shares	Sole	2026-01-23
2025-09-30	$4,941	191	+5.5%	Shares	Sole	2025-10-14
2025-06-30	$3,683	181	+223.2%	Shares	Sole	2025-07-11
2025-03-31	$1,016	56	-53.3%	Shares	Sole	2025-04-14
2024-12-31	$3,032	120	-62.8%	Shares	Sole	2025-02-10
2024-09-30	$10,978	323	+0.9%	Shares	Sole	2024-10-29
2024-06-30	$11,843	320	+1500.0%	Shares	Sole	2024-07-31
2024-03-31	$839	20	0.0%	Shares	Sole	2024-05-14
2023-12-31	$793	20	+5.3%	Shares	Sole	2024-02-15
2023-09-30	$522	19	-94.0%	Shares	Sole	2023-11-14
2023-06-30	$10,789	318	-90.1%	Shares	Sole	2024-05-14
2023-03-31	$116,143	3,228	—	Shares	Sole	2024-05-14
No filing history on record for this holder in this stock.